Rasagiline (1mg) & Rasagail 1.0
Rasagiline (1mg), featuring Rasagiline in its 1.0mg dosage form, stands as a beacon of hope for individuals battling Parkinson's disease. This comprehensive guide aims to shed light on the efficacy, dosage, side effects, and other crucial aspects of Rasagail 1.0 empowering patients and caregivers with essential knowledge for effective disease management.
Understanding Rasagiline (1.0mg)
Rasagiline, a monoamine oxidase type B (MAO-B) inhibitor, plays a pivotal role in the treatment of Parkinson's disease (पार्किंसंस रोग) by enhancing dopamine levels in the brain. At its 1.0mg strength, Rasagiline offers a potent therapeutic option for alleviating motor symptoms and improving the overall quality of life in Parkinson's patients.
Benefits of Rasagail 1.0
Motor Symptom Relief: Rasagail 1.0 effectively targets the motor symptoms of Parkinson's disease, including tremors, rigidity, and bradykinesia, facilitating smoother movements and enhanced mobility.
Disease Progression Delay: Studies suggest that Rasagiline may possess neuroprotective properties, potentially slowing the progression of Parkinson's disease and preserving neuronal function over time.
Reduced "Off" Time: By prolonging the duration of effectiveness of levodopa/carbidopa therapy, Rasagiline helps minimize the "off" periods characterized by the return of Parkinson's symptoms.
Enhanced Quality of Life: Patients treated with Rasagiline often report improvements in daily functioning, mood, and overall well-being, contributing to a better quality of life.
Dosage Guidelines
Initial Dose: The recommended starting dose of Rasagiline is typically 0.5mg once daily.
Titration: Depending on the patient's response and tolerability, the dosage may be increased to 1.0mg once daily after several weeks of treatment.
Administration: Rasagiline can be taken with or without food, but consistency in administration time is essential to maintain steady drug levels in the body.
Special Populations: Dose adjustments may be necessary for patients with hepatic impairment or those taking certain medications that interact with Rasagiline.
Potential Side Effects
While Rasagail 1.0 is generally well-tolerated, it may cause some side effects, including:
- Nausea
- Dizziness
- Insomnia
- Hypotension
Precautions and Considerations
- Hypertensive Crisis: Patients should avoid consuming foods rich in tyramine, as Rasagiline can potentiate the hypertensive effects of tyramine-containing substances.
- Drug Interactions: Rasagiline may interact with other medications, including antidepressants, opioids, and certain over-the-counter drugs, necessitating careful monitoring and potential dosage adjustments.
- Pregnancy and Lactation: The safety of Rasagiline in pregnant or breastfeeding women has not been established, and its use should be carefully considered in these populations.
Conclusion
In conclusion, Rasagail 1.0 represents a valuable addition to the armamentarium of Parkinson's disease management. By harnessing the neuroprotective and symptomatic relief properties of Rasagiline, patients can aspire to lead fuller, more functional lives despite the challenges posed by this debilitating condition. With proper dosage, monitoring, and adherence to precautions, Rasagail 1.0 paves the way toward a brighter tomorrow for individuals grappling with Parkinson's disease. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.
For further information:
EMAIL: info@sterispharma.com / contact@sterispharma.com
CALL/WHATSAPP: 7877551268, 7849827488